David B. Beck
Impact in
- Genetics top 2%
- Vascular Anomalies and Treatments
- Rheumatology top 1%
- Otitis Media and Relapsing Polychondritis
Papers in
- Rheumatology 36
- Otitis Media and Relapsing Polychondritis 35
-
- RNA modifications and cancer 6
- Cancer-related gene regulation 6
- Epigenetics and DNA Methylation 6
- Ubiquitin and proteasome pathways 6
- Co-authors
- Danny Reinberg (6 shared papers)Hisanobu Oda (3 shared papers)Steven S. Shen (1 shared paper)William J. Drury (3 shared papers)Philipp Voigt (2 shared papers)Daniel L. Kastner (10 shared papers)Achim Werner (10 shared papers)Benjamin A. García (2 shared papers)
- Journals
- Blood (7 papers)Arthritis & Rheumatology (4 papers)Blood Advances (3 papers)Lara D. Veeken (3 papers)Genes & Development (3 papers)
- Partner nations
- United StatesFranceNetherlands
In The Last Decade
David B. Beck
56 papers receiving 2.5k citations
David B. Beck's Hit Papers
Peers
Comparison fields: 5 of 98
- Genetics 533
- Rheumatology 748
- Geriatrics and Gerontology 163
- Molecular Biology 1.4k
- Physiology 59
Countries citing papers authored by David B. Beck
This map shows the geographic impact of David B. Beck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David B. Beck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David B. Beck more than expected).
Fields of papers citing papers by David B. Beck
This network shows the impact of papers produced by David B. Beck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David B. Beck. The network helps show where David B. Beck may publish in the future.
Co-authors
The 25 scholars most cited alongside David B. Beck, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 317 | |
| 2 | 2012 | 257 | |
| 3 | 2013 | 224 | |
| 4 | 2010 | 200 | |
| 5 | 2011 | 171 | |
| 6 | Benign and malignant hematologic manifestations in patients with VEXAS syndrome due to somatic mutations in UBA1 Hit paper breakdown → | 2021 | 139 |
| 7 | 2021 | 128 | |
| 8 | Estimated Prevalence and Clinical Manifestations of UBA1 Variants Associated With VEXAS Syndrome in a Clinical Population Hit paper breakdown → | 2023 | 113 |
| 9 | 2003 | 96 | |
| 10 | 2012 | 92 | |
| 11 | 2022 | 72 | |
| 12 | 2021 | 65 | |
| 13 | 2021 | 64 | |
| 14 | 2019 | 51 | |
| 15 | 2020 | 40 | |
| 16 | 2023 | 37 | |
| 17 | 2020 | 34 | |
| 18 | 2023 | 33 | |
| 19 | 2020 | 27 | |
| 20 | 2021 | 26 |
About David B. Beck
David B. Beck is a scholar working on Rheumatology, Molecular Biology, Immunology, Genetics and Oncology, having authored 62 papers that have together received 2.5k indexed citations. Recurring topics across this work include Otitis Media and Relapsing Polychondritis (35 papers), Immunodeficiency and Autoimmune Disorders (12 papers), Vascular Anomalies and Treatments (12 papers), Peptidase Inhibition and Analysis (8 papers), RNA modifications and cancer (6 papers), Cancer-related gene regulation (6 papers), Epigenetics and DNA Methylation (6 papers) and Ubiquitin and proteasome pathways (6 papers). The work is most often cited by research in Genetics (533 citations), Rheumatology (748 citations), Geriatrics and Gerontology (163 citations), Molecular Biology (1.4k citations) and Physiology (59 citations). David B. Beck has collaborated with scholars based in United States, France and Netherlands. Frequent co-authors include Danny Reinberg, Hisanobu Oda, Steven S. Shen, William J. Drury, Philipp Voigt, Daniel L. Kastner, Achim Werner, Benjamin A. García, Nicolas L. Young and Ivona Aksentijevich. Their work appears in journals such as Blood, Arthritis & Rheumatology, Blood Advances, Lara D. Veeken and Genes & Development.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.